9 active
/
40 total (since 2015)
2
Phase 1 Active
9 total
5
Phase 2 Active
14 total
5
Phase 3 Active
12 total
1
Phase 4 Active
11 total
Top Sponsors (Industry)
Sorted by active Active Done Failed
RVL Pharmaceuticals, Inc. 1 2 0
Ipsen 1 1 0
Merz Pharmaceuticals GmbH 1 0 0
Chongqing Claruvis Pharmaceutical Co., Ltd. 1 0 0
Elpida Therapeutics SPC 1 0 0
Medy-Tox 0 3 0
NCT03992404 ACTIVE NOT RECRUITING
Study to Compare the Efficacy and Safety of NT 201 (Botulinum Toxin) With Placebo for the Treatment of Lower Limb Spasticity Caused by Stroke or Traumatic Brain Injury
Merz Pharmaceuticals GmbH n=603
NCT06783114 RECRUITING
A Clinical Study on Recombinant Botulinum Toxin Type A (YY001) for Injection in The Treatment of Upper Limb Spasticity in Adults
Chongqing Claruvis Pharmaceutical Co., Ltd. n=254
NCT05179577 NOT YET RECRUITING
A Study to Investigate Arbaclofen ER Tablets for the Treatment of Spasticity in Patients With Multiple Sclerosis
RVL Pharmaceuticals, Inc. n=442
NCT07242300 NOT YET RECRUITING
Efficacy and Safety of Recombinant Botulinum Toxin Type A (Eveotox) for Injection in the Treatment of Adult Upper Limb Spasticity .
JHM BioPharma (Tonghua) Co. , Ltd. n=207
NCT06536751 RECRUITING
Therapeutic Photobiomodulation and Tretament of Spasticity
University of Nove de Julho n=28
NCT06863662 COMPLETED
Efficacy and Safety of Etoricoxib/Tizanidine Versus Etoricoxib for Acute Low Back Pain Associated to Muscle Spasm
Laboratorios Silanes S.A. de C.V. n=136
NCT05289921 COMPLETED
To Evaluate HU-014 in the Treatment of Post Stroke Upper Limb
Huons Co., Ltd. n=198
NCT03319732 COMPLETED
A Study to Evaluate the Long-term Safety of Arbaclofen Extended-Release Tablets for Patients With Spasticity Due to MS
RVL Pharmaceuticals, Inc. n=323
NCT03290131 COMPLETED
A Study to Investigate the Safety and Effectiveness of Arbaclofen Extended-Release Tablets for Patients With MS
RVL Pharmaceuticals, Inc. n=536
NCT04671082 COMPLETED
Efficacy and Safety of Tolperisone in Subjects With Pain Due to Acute Back Muscle Spasm
Neurana Pharmaceuticals, Inc. n=1,004
NCT03289702 COMPLETED
CORETOX® in Treatment of Post Stroke Upper Limb Spasticity (Phase3)
Medy-Tox n=220
NCT03261167 COMPLETED
A Phase III Study to Evaluate the Efficacy and Safety of GSK1358820 in Subjects With Post-stroke Upper Limb Spasticity
GlaxoSmithKline n=124
Data: ClinicalTrials.gov